Is maternal renal disease a cause of elevated free β-hCG in first trimester aneuploidy screening?

Prenatal Diagnosis

Volumn 29, Issue 11, 2009, Pages 1045-1049

  Spencer, Kevin ^a   Enofe, Osasumwen ^a   Cowans, Nicholas J ^a   Stamatopoulou, Anastasia ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

Free hCG; PAPP A; Prenatal screening; Renal disease; Trisomy

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CREATININE;

ADULT; ANEUPLOIDY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; GLOMERULUS FILTRATION RATE; HEALTH HAZARD; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; TRIPLOIDY; TRISOMY 21;

ADULT; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DIAGNOSIS, DIFFERENTIAL; DOWN SYNDROME; FEMALE; HUMANS; KIDNEY DISEASES; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; UP-REGULATION; YOUNG ADULT;

EQUUS ASINUS;

EID: 70350447847     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2347     Document Type: Article

References (40)

1. Bucker CL, Wilson L, Papadea CN. 2007. Case report: an unusual cause of elevated serum total beta-hCG. Ann Clin Lab Sci 37: 186-191. (Pubitemid 46717199)
2. Burden R, Tomson C. 2005. Identification, management and referral of adults with chronic kidney disease: concise guidelines. Clin Med 5: 635-642. (Pubitemid 41826495)
3. Byrd LM, Baker P. 2006. Impaired renal function in the mother may result in high false positive rate in Down Syndrome screening. J Obstet Gynaecol 26: 376-377. (Pubitemid 43869792)
4. Cararach V, Casals E, Martinez S, et al. 1997. Abnormal renal function as a cause of false positive biochemical screening for Down's syndrome. Lancet 350: 1295. (Pubitemid 28036640)
5. Chai A-S, Hunag J-Y, Lien R, Kung F-T, Chen P-J, Hsieh PCC. 2002. Pregnancy in women who undergo long term hemodialysis. Am J Obstet Gynecol 187: 152-156. (Pubitemid 34800314)
6. Cheng P-J, Liu C-M, Chang S-D, Lin Y-T, Soong Y-K. 1999. Elevated second trimester maternal serum hCG in patients undergoing hemodialysis. Prenat Diagn 19: 955-958.
7. Cole LA, Kardana A, Andrade-Gordon P. 1991. The heterogeneity of hCG. III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 129: 1559-1567.
8. Davison JM, Noble MC. 1981. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. BJOG 88: 10-17.
9. Kagan KO, Frisova V, Nicolaides KH, Spencer K. 2007. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13 + 6 weeks of gestation. Prenat Diagn 27: 849-853. (Pubitemid 47425405)
10. Karidas CN, Michailidis GD, Spencer K, Economides DL. 2002. Biochemical screening for Down syndrome in pregnancies following renal transplantation. Prenat Diagn 22: 226-230. (Pubitemid 34245838)
11. Kardana A, Cole LA. 1990a. hCG beta-subunit nicking enzymes in pregnancy and cancer patient serum. J Clin Endocrinol Metab 79: 761-767.
12. Kardana A, Cole LA. 1990b. Serum beta-core fragment is masked by associated macromolecules. J Clin Endocrinol Metab 71: 1393-1395. (Pubitemid 20386352)
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
14. Levey AS, Coresh J, Greene T, et al. 2006. Using standardized serum creatinine values in the modification of diet renal study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254. (Pubitemid 46768608)
15. Morgan FJ, Birken S, Cranfield RE. 1975. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and the beta subunit. J Biol Chem 250: 5247-5248.
16. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25: 221-226. (Pubitemid 40432687)
17. Norman RJ, Buchholz M-M, Somogyi AA, Amato F. 2000. hCG beta core fragment is a metabolite of hCG: evidence from infusion of recombinant hCG. J Endocrinol 164: 299-305. (Pubitemid 30163672)
18. Rosa C, Amr S, Birken S, et al. 1984. Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans. J Clin Endocrinol Metab 59: 1215-1219. (Pubitemid 15223363)
19. Sakakibara R, Miyazaki S, Ishiguro M. 1990. A nicked beta-subunit of human chorionic gonadotropin purified from pregnancy urine. J Biochem 107: 858-862. (Pubitemid 20186298)
20. Schwarz A, Post KG, Keller F, Molzahn M. 1985. Value of human chorionic gonadotropin measurement in blood as a pregnancy test in women on maintenance dialysis. Nephron 39: 341-343. (Pubitemid 15131296)
21. Shenhav S, Gemer O, Sherman DJ, Peled R, Segal S. 2003. Midtrimester triple test levels in women with chronic hypertension and altered renal function. Prenat Diagn 23: 166-167. (Pubitemid 36245152)
22. Shulman LP, Briggs R, Phillips OW, Friedman SA, Sibai B. 1998. Renal hemodialysis and maternal serum triple analyte screening. Fetal Diagn Ther 13: 26-28. (Pubitemid 28171758)
23. Smith MC, Moran P, Ward MK, Davison JM. 2008. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 115: 109-112. (Pubitemid 350209609)
24. Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. 1999. Maternal age and gestational specific risk for trisomy 21. Ultrasound Obstet Gynecol 13: 167-170. (Pubitemid 29176889)
25. Spencer K. 1986. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 23: 1-25. (Pubitemid 16178799)
26. Spencer K, Macri JN, Aitken DA, Connor JM. 1992. Free beta-hCG as first-trimester marker for fetal trisomy. Lancet 339: 8807.
27. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13(4): 231-237. (Pubitemid 29248329)
28. Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH. 2000a. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20: 495-499. (Pubitemid 30394277)
29. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH. 2000b. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20: 411-416. (Pubitemid 30261164)
30. Spencer K, Tul N, Nicolaides KH. 2000c. Maternal serum free betah-CG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 20: 390-394.
31. Spencer K, Spencer CE, Power M,Moakes A, Nicolaides KH. 2000d. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 107: 1271-1275.
32. Spencer K, Ong CY, Liao AW, Nicolaides KH. 2000e. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 20: 491-494.
33. Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. 2000f. First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status. Prenat Diagn 20: 852-853.
34. Spencer K, Bindra R, Nix ABJ, Heath V, Nicolaides KH. 2003a. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?. Ultrasound Obstet Gynecol 22: 142-148. (Pubitemid 36976380)
35. Spencer K, Bindra R, Nicolaides KH. 2003b. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23(10): 851-855. Oct. (Pubitemid 37279873)
36. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24(3): 169-173. Mar. (Pubitemid 38428854)
37. Spencer K, Heath V, El-Sheikhah A, Ong CYT, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25(5): 365-369. May. (Pubitemid 40813777)
38. Tul N, Spencer K, Noble P, Chan C, Nicolaides K. 1999. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 19(11): 1035-1042. Nov.
39. Wehmann RE, Nisula BC. 1981. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest 68: 184-194. (Pubitemid 11048091)
40. Wide L, Johanisson E, Tillinger KG, Diczfalusy E. 1968. Metabolic clearance of human chorionic gonadotropin administered to non pregnant women. Acta Endocrinol 59: 579-594.